NeoPharm Co Ltd
KOSDAQ:092730
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
310.5B KRW |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
198.4B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
118.4B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
36.7B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
38.9B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23.5B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
3.1T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
909B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
NeoPharm Co Ltd
Glance View
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for NeoPharm Co Ltd is 66.2%, which is above its 3-year median of 65.3%.
Over the last 3 years, NeoPharm Co Ltd’s Gross Margin has decreased from 69.4% to 66.2%. During this period, it reached a low of 60.5% on Sep 30, 2024 and a high of 69.4% on Sep 30, 2022.
